(Q41449030)

30 September 2017

Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem (English)

1 reference

30 September 2017

Gafni A

1

1 reference

30 September 2017

Birch S

series ordinal

2

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 March 1993

1 reference

30 September 2017

5

1 reference

Canadian Medical Association Journal

inferred from page(s)

published in

1 reference

30 September 2017

148

1 reference

30 September 2017

6

1 reference

30 September 2017

913-917

1 reference

Economic evaluation of drug therapy: a review of the contingent valuation method

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Equity considerations in utility-based measures of health outcomes in economic appraisals: an adjustment algorithm

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Preferences for health outcomes. Comparison of assessment methods

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

The use of QALYs in health care decision making

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Measuring the adverse effects of unnecessary hypertension drug therapy: QALYs vs HYE.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Applications of cost-benefit analysis to health care. Departures from welfare economic theory.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Quality-adjusted life years, utility theory, and healthy-years equivalents

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Ionic versus nonionic contrast media: a burden or a bargain?

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

The healthy-years equivalents: how to measure them using the standard gamble approach

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1490730

Evaluation of public investment in health care. Is the risk irrelevant?

11 June 2018

1 reference

12 December 2020

Evaluating health related quality of life: an indifference curve interpretation for the time trade-off technique

1 reference

12 December 2020

QALYs and the equity-efficiency trade-off

1 reference

12 December 2020

Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs

1 reference

12 December 2020

Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis

1 reference

12 December 2020

Identifiers

1 reference

30 September 2017

PubMed publication ID

8448705

1 reference